|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1331 Pennsylvania Ave NW |
Address2 | Suite 1425 North |
City | WASHINGTON |
State | DC |
Zip Code | 20004-1710 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60601 |
Country | USA |
|
5. Senate ID# 2811-12
|
||||||||
|
6. House ID# 305490000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul G Billings |
Date | 1/22/2019 2:03:08 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to the President's Budget; H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; S.2976 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; H.R.6147 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019; S.3073 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019; H.R.6385 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2019; S.3108 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2019; H.Con.Res.128 - Establishing the congressional budget for the United States Government for fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028; H.J.Res.143 - Making further continuing appropriations for fiscal year 2019, and for other purposes; H.R. 695 Further Additional Continuing Appropriations Act, 2019;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to the President's Budget; Issues related to the Budget Control Act; Issues related to regulatory reforms; appropriations issues; H.R.5, Regulatory Accountability Act of 2017; H.R.350, Recognizing the Protection of Motorsports Act of 2017; H.R.453, Relief from New Source Performance Standards Act of 2017; H.R.806, Ozone Standards Implementation Act of 2017; H.R.1119, SENSE Act; H.R.1430, HONEST Act; H.R.1431, EPA Science Advisory Board Reform Act of 2017; H.R.1917, Blocking Regulatory Interference from Closing Kilns Act of 2017; H.R.3107, Diesel Emissions Reduction Act of 2017; H.R.3782, Climate Change Health Protection and Promotion Act of 2017; H.R.4011, Fuel Economy Harmonization Act; H.R.6147, Interior, Environment, Financial Services and General Government, Agriculture, Rural Development, Food and Drug Administration, and Transportation, Housing and Urban Development Appropriations Act, 2019; H.R.6463, MARKET CHOICE Act; H.R.7173, Energy Innovation and Carbon Dividend Act of 2018; S.263, Ozone Standards Implementation Act of 2017; S.517, Consumer and Fuel Retailer Choice Act; S.839, Blocking Regulatory Interference from Closing Kilns Act of 2017; S.951, Regulatory Accountability Act of 2017; S.1203, A bill to require the Administrator of the Environmental Protection Agency to establish a program under which the Administrator shall defer the designation of an area as a nonattainment area for purposes of the 8-hour ozone national ambient air quality standard if the area achieves and maintains certain standards under a voluntary early action compact plan.; S.1273, Fuel Economy Harmonization Act; S.1447, Diesel Emissions Reduction Act of 2017; S.1807, Climate Change Health Protection and Promotion Act of 2017; S.1857, A bill to establish a compliance deadline of May 15, 2023, for Step 2 emissions standards for new residential wood heaters, new residential hydronic heaters, and forced-air furnaces.; S.2461, Blocking Regulatory Interference from Closing Kilns Act of 2018; S.3073, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019; S.3791, A bill to create a Carbon Dividend Trust Fund for the American people in order to encourage market-driven innovation of clean energy technologies and market efficiencies which will reduce harmful pollution and leave a healthier, more stable, and more prosperous nation for future generations.; S.3394, the Comprehensive National Mercury Monitoring Act; S.3779, WHERA Act; H.J.Res.143 - Making further continuing appropriations for fiscal year 2019, and for other purposes; H.R. 695 Further Additional Continuing Appropriations Act, 2019;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA), Office of Management & Budget (OMB), Natl Highway Traffic Safety Administration (NHTSA), Transportation - Dept of (DOT)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to the President's Budget; H.R.774 Medicaid Coverage of Tobacco Cessation Nonprescription Drugs Act H.R.1121 Pre-existing Conditions Protection Act of 2017; H.R.2550 Medicare Telehealth Parity Act of 2017; H.R.4695 Bipartisan Market Stabilization and Innovation Act of 2017; H.R.4897 Women and Lung Cancer Research and Preventive Services Act of 2018; S.974 CREATES Act of 2017; S.1462 Marketplace Certainty Act; S.2494 Fair Care Act; S.2507 Improving Choices in Health Care Coverage Act; S. 2507, Improving Choices in Health Care Coverage Act (Codification of Short Term Limited Duration Health Plans); H.Con.Res.128 - Establishing the congressional budget for the United States Government for fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028 H.R.2 Agriculture and Nutrition Act of 2018; S.3388 - Ensuring Coverage for Patients with Pre-Existing Conditions Act; H.R.4229 - Protecting HOME Access Act of 2017; S.J.Res.63 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury, Secretary of Labor, and Secretary of Health and Human Services relating to "Short-Term, Limited Duration Insurance
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Housing & Urban Development - Dept of (HUD), Office of Management & Budget (OMB), White House Office, Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to lung disease treatment, prevention and research; Issues related to the President's Budget; H.Con.Res.128 - Establishing the congressional budget for the United States Government for fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; Issues related to tobacco cessation; Issues related to the President's Budget; Issues related to Medicaid waivers; Issues related to the Affordable Care Act; Issues related to oxygen; Issues related to access to healthcare; H.R.2550, Medicare Telehealth Parity Act of 2017; H.R.4229, Protecting HOME Access Act of 2017;H.R.4667, H.R.4695, Bipartisan Market Stabilization and Innovation Act of 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
Issues related to nonprofit postal rates;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Postal Regulatory Commission
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues related to lung disease treatment and prevention, and public health; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to Tobacco 21; Issues related to the Tobacco Control Act: Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to the President's Budget; Issues related to tobacco prevention; H.R.5, Regulatory Accountability Act of 2017; H.R.21, Midnight Rules Relief Act of 2017; H.R.564, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017; H.R.729, Tobacco Excise Tax and Parity Act of 2017; H.R.1136, FDA Deeming Authority Clarification Act of 2017;H.R.1662, To amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes.; H.R.1848, Veterans Affairs Medical Scribe Pilot Act of 2017; H.R.2194, Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017; H.R.2430, FDA Reauthorization Act of 2017; H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; S.2976 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; H.R.6385 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2019; S.3108 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2019; H.R.4273, Tobacco to 21 Act; S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017; S.934, FDA Reauthorization Act of 2017; S.951, Regulatory Accountability Act of 2017; SS.1837, Tobacco Tax Equity Act of 2017; S.2100, Tobacco to 21 Act; S.2119, A bill to amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes.;S. 3319 Stopping Appealing Flavors in E-Cigarettes for Kids Act; H.J.Res.143 - Making further continuing appropriations for fiscal year 2019, and for other purposes; H.R. 695 Further Additional Continuing Appropriations Act, 2019;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Housing & Urban Development - Dept of (HUD), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to the President's Budget; H.R.729 Tobacco Excise Tax and Parity Act of 2017; S.1837 - Tobacco Tax Equity Act of 2017; H.Con.Res.128 - Establishing the congressional budget for the United States Government for fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the President's Budget; H.R.1848, Veterans Affairs Medical Scribe Pilot Act of 2017; S.2119, A bill to amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |